share_log

欧康维视生物-B(01477.HK)遭Temasek Holdings (Private) Limited减持82.8万股

Ocumension Therapeutics-B (01477.HK) was subjected to a shareholding reduction of 0.828 million shares by Temasek Holdings (Private) Limited.

Gelonghui Finance ·  Jul 17, 2024 22:38

According to the latest equity disclosure data from the Stock Exchange, on July 15, 2024, Eucon Holding Group-B (01477.HK) was reduced by Temasek Holdings (Private) Limited by 0.828 million shares at an average price of HKD 6.9161 per share, involving about HKD 5.7265 million.

After the reduction, Temasek Holdings (Private) Limited's latest shareholding amount is 41.4354 million shares, and the shareholding ratio has decreased from 6.09% to 5.97%.

big
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 233

Recommended

Write a comment

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.